Navigation Links
ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbine™ NDA
Date:1/19/2011

tential for the FDA to impose other requirements to be completed before or after approval of the Exelbine NDA, including that the FDA may require ADVENTRX to perform additional nonclinical, bioequivalence or clinical studies; ADVENTRX's reliance on third parties to assist with its bioequivalence trials, regulatory submissions, manufacturing and other important aspects of the Exelbine development program, and the risk that FDA approval may be delayed if their performance is found to have been substandard; the risk that any patent issued to ADVENTRX may not provide sufficient protection and market exclusivity for Exelbine and may be challenged, invalidated, infringed or circumvented by third parties, including by ADVENTRX's competitors; ADVENTRX's dependence on the success of Exelbine as its first product candidate to be submitted for regulatory approval; the potential that ADVENTRX may require substantial additional funding to obtain FDA approval for and commercialize Exelbine, and the risks inherent in these activities; the potential for ADVENTRX to enter into a commercial partnership or other strategic transaction relating to Exelbine and that such partnership or transaction may not succeed in commercializing Exelbine; and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at www.sec.gov.  

You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date when made. ADVENTRX does not intend to revise or update any forward-looking statement set forth in this press release to reflect events or circumstances arising after the date hereof, except as may be required by law.


'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
3. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
4. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
5. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
6. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
8. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
9. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
10. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
11. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 4, 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... Ch.B., Sangamo,s executive vice president, research and development, will ... Therapeutic ® development programs and an overview of ... August 11, 2015, at the 2015 Wedbush Pacgrow Healthcare ... New York, NY . The presentation ...
(Date:8/4/2015)... Aug. 04, 2015 ... the addition of the "MRI Systems Market ... Operational Efficiency, with Growth Driven by Developing Economies" ... Systems Market to 2020 - Focus on Patient ... Developing Economies" discusses the market, competitive landscape, and ...
(Date:8/4/2015)... 2015  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) ... million for the three and six months ended June ... $12.1 million and $43.4 million for the same periods ... primarily by the more than $90 million of revenue ... upfront payment from Bayer to license  ISIS-FXI Rx .  ...
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference 2Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16
... 9, 2011 Lpath, Inc. (OTC: LPTN), the category ... 5th RetailInvestorConferences.com presentation is available for on-demand viewing. ... "register/ watch event now" button. Lpath, Inc.,s ... may download shareholder materials from the "virtual trade booth" ...
... Tenn., May 9, 2011 Muenster Memorial Hospital, ... serving a bi-county area north of Denton, Texas, ... Record as Muenster,s EMR solution, Michael Kent, Muenster ... ) (Logo: http://photos.prnewswire.com/prnh/20110503/CL93887LOGO-b ) ...
Cached Medicine Technology:Lpath, Inc. CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 2Lpath, Inc. CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 3Muenster Memorial Hospital Selects ChartSmart emr® 2Muenster Memorial Hospital Selects ChartSmart emr® 3
(Date:8/4/2015)... ... ... Atlantic Health System, one of the largest health care organizations in New Jersey, was ... list of the 20 Best Workplaces in Health Care. , Ranked at No. 4, ... and Atlantic Rehabilitation, is the highest-ranking company from New Jersey on the list. , ...
(Date:8/4/2015)... ... August 04, 2015 , ... Healthy Origins® ... Cognizin® is a trademark for Citicoline, a nutrient that supports memory function and ... applications which have more of a semi-solid composition. Vegetarian capsules are also ...
(Date:8/4/2015)... ... 04, 2015 , ... Angelina Jolie is in it at age 39. “It” ... Dr. Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” arguably the ... out of menopause. , Myth #1: Menopause only affects old ladies. – Menopause ...
(Date:8/4/2015)... ... ... School is almost back in session. Parents and children are enjoying the ... Dublin, OH family dentist , Dr. Cheung (of BrightSmile Dental) reminds parents that ... fact, the dentist recently updated the practice’s surgical suite to prepare for nervous children ...
(Date:8/4/2015)... ... August 04, 2015 , ... Many men are confused ... subject, Renew Man™ is standing up as a voice of authority for men seeking ... healthy aging industry with special experience and expertise in the safe and effective treatment ...
Breaking Medicine News(10 mins):Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 3Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 4Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 3Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 2Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 4Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3
... and apparently innocent blow to the chest may cause sudden cardiac ... a blow on the head that most people fear. According to ... hazardous. ,The researchers looked at 100 cases of a ... a blow on the chest. As many as 80 per cent ...
... bologna and bacon can increase the risk of type 2 ... appearing in the journal Diabetes Care, a group of Hopkins ... thousands of men and found that those who frequently ate ... type 2 diabetes than men who ate less of the ...
... scientists, from deCODE genetics and Iceland's National University Hospital, ... woman's risk by more than 62 per cent.//,Endometriosis is ... found only in the lining of the uterus, develops ... and organs in the abdominal cavity, but still responds ...
... the best indicators of how you might use prescription drugs. ... prescription drug use, where you live also can say a ... ,According to the study, the percentage of adult beneficiaries ... high of 71 percent in Kansas to a low of ...
... that an air pollutant emitted by power plants and ... increase your chances of dying from lung cancer or ... pollution. The study authors contend that simply living in ... matter" that makes its way into your lungs when ...
... is likely to be delayed as the mandatory inspection ... for the company's ANDA (Abbreviated New Drug Application) for ... investigator had not yet arrived. ,The US ... product. A special investigator for checking the manufacturing process ...
Cached Medicine News:Health News:Processed Meat, Diabetes connection Found 2Health News:Prescription Drug Use Varies Widely Between States 2
... seats and large backrests with lumbar support ... and casters and glides. • Choose the ... variety of environments including: industry, education, laboratory, ... office. • With tubular base • unit ...
... Durable ergonomic chairs with concave seats ... Select options like seats, backrests, armrests, and ... Series for top performance in a variety ... room, static control, health care and office. ...
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Medicine Products: